help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asa, S. L.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asa, S. L.
Right arrow Articles by Vale, W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH

Endocrinology, Vol 131, 2083-2089, Copyright © 1992 by Endocrine Society


ARTICLES

Pituitary adenomas in mice transgenic for growth hormone-releasing hormone

SL Asa, K Kovacs, L Stefaneanu, E Horvath, N Billestrup, C Gonzalez-Manchon and W Vale
Department of Pathology, St. Michael's Hospital University of Toronto, Ontario, Canada.

It has been shown that mice transgenic for human GH-releasing hormone (GRH) develop hyperplasia of pituitary somatotrophs, lactotrophs, and mammosomatotrophs, cells capable of producing both GH and PRL, by 8 months of age. We now report that GRH transgenic mice 10-24 months of age develop pituitary adenomas, which we characterized by histology, immunohistochemistry, in situ hybridization, and electron microscopy. Of 13 animals examined, all developed GH-immunoreactive neoplasms that had diffuse positivity for GH mRNA by in situ hybridization. Eleven also contained PRL immunoreactivity; in situ hybridization demonstrated focal PRL mRNA in 3 of 5 immunohistochemically positive tumors. Alpha- Subunit was positive by immunohistochemistry in 8 adenomas, and TSH beta was localized in tumor cells of 5 adenomas. The adenomas had variable ultrastructural appearances, ranging from cells that resembled somatotrophs or mammosomatotrophs to cells with features of the glycoprotein hormone cell line. These findings provide conclusive evidence that protracted GRH stimulation of secretory activity can result in proliferation, hyperplasia, and adenoma of adenohypophysial cells.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Nasr, A. Mason, M. Mayberg, S. M. Staugaitis, and S. L. Asa
Acromegaly and Somatotroph Hyperplasia with Adenomatous Transformation Due to Pituitary Metastasis of a Growth Hormone-Releasing Hormone-Secreting Pulmonary Endocrine Carcinoma
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4776 - 4780.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ezzat, X. Zhu, S. Loeper, S. Fischer, and S. L. Asa
Tumor-Derived Ikaros 6 Acetylates the Bcl-XL Promoter to Up-Regulate a Survival Signal in Pituitary Cells
Mol. Endocrinol., November 1, 2006; 20(11): 2976 - 2986.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Donangelo, S. Gutman, E. Horvath, K. Kovacs, K. Wawrowsky, M. Mount, and S. Melmed
Pituitary Tumor Transforming Gene Overexpression Facilitates Pituitary Tumor Development
Endocrinology, October 1, 2006; 147(10): 4781 - 4791.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Siriwardana, A. Bradford, D. Coy, and P. Zeitler
Autocrine/Paracrine Regulation of Breast Cancer Cell Proliferation by Growth Hormone Releasing Hormone via Ras, Raf, and Mitogen-Activated Protein Kinase
Mol. Endocrinol., September 1, 2006; 20(9): 2010 - 2019.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan
The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. T. McElvaine and K. E. Mayo
A Dominant-Negative Human Growth Hormone-Releasing Hormone (GHRH) Receptor Splice Variant Inhibits GHRH Binding
Endocrinology, April 1, 2006; 147(4): 1884 - 1894.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Huerta-Ocampo, H. C. Christian, N. M. Thompson, M. M. El-Kasti, and T. Wells
The Intermediate Lactotroph: A Morphologically Distinct, Ghrelin-Responsive Pituitary Cell in the Dwarf (dw/dw) Rat
Endocrinology, November 1, 2005; 146(11): 5012 - 5023.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Lania, G. Mantovani, and A. Spada
Genetics of Pituitary Tumors: Focus on G-Protein Mutations
Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. S. Khan, M. L. Fiorotto, K. K. Cummings, M. A. Pope, P. A. Brown, and R. Draghia-Akli
Maternal GHRH plasmid administration changes pituitary cell lineage and improves progeny growth of pigs
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E224 - E231.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. B. Rulli, A. Kuorelahti, O. Karaer, L. J. Pelliniemi, M. Poutanen, and I. Huhtaniemi
Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin
Endocrinology, October 1, 2002; 143(10): 4084 - 4095.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. S. Khan, M. L. Fiorotto, L.-A. Hill, P. B. Malone, K. K. Cummings, D. Parghi, R. J. Schwartz, R. G. Smith, and R. Draghia-Akli
Nonhereditary Enhancement of Progeny Growth
Endocrinology, September 1, 2002; 143(9): 3561 - 3567.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman
The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling
Endocrinology, September 1, 2001; 142(9): 3764 - 3773.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Pombo, J. Zalvide, B. D. Gaylinn, and C. Dieguez
Growth Hormone-Releasing Hormone Stimulates Mitogen-Activated Protein Kinase
Endocrinology, June 1, 2000; 141(6): 2113 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. L. Asa, K. T. Coschigano, L. Bellush, J. J. Kopchick, and S. Ezzat
Evidence for Growth Hormone (GH) Autoregulation in Pituitary Somatotrophs in GH Antagonist-Transgenic Mice and GH Receptor-Deficient Mice
Am. J. Pathol., March 1, 2000; 156(3): 1009 - 1015.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. P. Moore Jr., A. Cai, M. E. Hostettler, L. A. Arbogast, J. L. Voogt, and J. F. Hyde
Pituitary Hormone Gene Expression and Secretion in Human Growth Hormone-Releasing Hormone Transgenic Mice: Focus on Lactotroph Function
Endocrinology, January 1, 2000; 141(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. L. Asa, M. A. Kelly, D. K. Grandy, and M. J. Low
Pituitary Lactotroph Adenomas Develop after Prolonged Lactotroph Hyperplasia in Dopamine D2 Receptor-Deficient Mice
Endocrinology, November 1, 1999; 140(11): 5348 - 5355.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Roudbaraki, A. Lorsignol, L. Langouche, G. Callewaert, H. Vankelecom, and C. Denef
Target Cells of {gamma}3-Melanocyte-Stimulating Hormone Detected through Intracellular Ca2+ Responses in Immature Rat Pituitary Constitute a Fraction of All Main Pituitary Cell Types, but Mostly Express Multiple Hormone Phenotypes at the Messenger Ribonucleic Acid Level. Refractoriness to Melanocortin-3 Receptor Blockade in the Lacto-Somatotroph Lineage
Endocrinology, October 1, 1999; 140(10): 4874 - 4885.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. L. Asa and S. Ezzat
The Cytogenesis and Pathogenesis of Pituitary Adenomas
Endocr. Rev., December 1, 1998; 19(6): 798 - 827.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barlier, G. Gunz, A. J. Zamora, I. Morange-Ramos, D. Figarella-Branger, H. Dufour, A. Enjalbert, and P. Jaquet
Pronostic and Therapeutic Consequences of Gs{alpha} Mutations in Somatotroph Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1604 - 1610.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. Petersenn, A. C. Rasch, M. Heyens, and H. M. Schulte
Structure and Regulation of the Human Growth Hormone-Releasing Hormone Receptor Gene
Mol. Endocrinol., February 1, 1998; 12(2): 233 - 247.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Kovacs, R. D. Kineman, A. V. Schally, M. Zarandi, K. Groot, and L. A. Frohman
Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) on GH and Insulin-Like Growth Factor I Levels in Transgenic Mice Overexpressing the Human GHRH Gene, an Animal Model of Acromegaly
Endocrinology, November 1, 1997; 138(11): 4536 - 4542.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sanno, A. Teramoto, R. Y. Osamura, S. Genka, H. Katakami, L. Jin, R. V. Lloyd, and K. Kovacs
A Growth Hormone-Releasing Hormone-Producing Pancreatic Islet Cell Tumor Metastasized to the Pituitary Is Associated with Pituitary Somatotroph Hyperplasia and Acromegaly
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2731 - 2737.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. A. Abbass, S. L. Asa, and S. Ezzat
Altered Expression of Fibroblast Growth Factor Receptors in Human Pituitary Adenomas
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1160 - 1166.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Jaffe, R. DeMott-Friberg, L. A. Frohman, and A. L. Barkan
Suppression of Growth Hormone (GH) Hypersecretion due to Ectopic GH-Releasing Hormone (GHRH) by a Selective GHRH Antagonist
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 634 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Benlot, L. Levy, P. Fontanaud, A. Roche, P. Rouannet, and D. Joubert
Somatostatin and Growth Hormone-Releasing Hormone in Normal and Tumoral Human Breast Tissue: Endogenous Content, in Vitro Pulsatile Release, and Regulation
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 690 - 696.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society